Arch Pharmalabs Limited Announces Partnership With Orochem Technologies to Supply API for U.S. Innovator's Late-Stage Clinical Development Program

Published: Oct 12, 2009

MADRID--(BUSINESS WIRE)--Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator’s active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology. Orochem Technologies manufactures SMB equipment and stationary chromatography phases for Bioanalytical, Solid Phase Extraction, Flash and Preparative applications. Financial terms were not disclosed.

Back to news